3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Lymphoid
3
Other hematologic neoplasm
2
Classical hematology
1
Interventions
selpercatinib
2
lutetium Lu 177 dotatate
2
entrectinib
2
cabozantinib
2
Fulvestrant
2
trametinib
1
ribociclib
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
dabrafenib
1
copper dotatate CU-64
1
belzutifan
1
X-Rays
1
Specimen Handling
1
Phantoms, Imaging
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
Alpelisib
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
ibrutinib
×
Endocrine
×
Clear all
No trials found.